Alfanova 0.15% eye drops 5 ml

Tradename

Alfanova

Alphanova

Composition

Each ml contains:

brimonidine tartrate 1.5 mg

Auxiliary components:

Sodium chloride.

Properties

Brimonidine is a selective alpha2-adrenergic agonist that has a stimulating effect on alpha2-adrenergic receptors. When used in a dosage form of 0.15% eye drops, the maximum decrease in intraocular pressure (IOP) is achieved after 2 hours. The hypotensive effect of brimonidine is provided by reducing the formation and increasing the outflow of intraocular fluid along the uveoscleral pathway.

Indications

— open-angle glaucoma;

-phthalmohypertension (in monotherapy or in combination with other drugs that lower IOP).

Method of administration and dosage:

Contraindications

-increased sensitivity to brimonidine and other components of the drug;

— simultaneous therapy with MAO inhibitors;

-Children up to 2 years old, low body weight (up to 20 kg);

Side effects

From the side of the organ of vision: very often — allergic conjunctivitis, conjunctival hyperemia, itching of the mucous membrane of the eyes and skin of the eyelids; often — burning sensation, follicular conjunctiva or follicular conjunctivitis, local allergic reactions from the eyes (including keratoconjunctivitis), blepharitis, blepharoconjunctivitis, blurred vision, cataracts, conjunctival edema.

From the side of the central nervous system: often — headache, drowsiness, insomnia, dizziness.

From the side of the cardiovascular system: often — increased blood pressure; infrequently — a decrease in blood pressure.